AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Sponsored Reports
Loading...
| Previous Close (in USD) | 7.54 |
|---|---|
| Change | -0.450 5.968% |
| 52 W H/L (in USD) | 34.360/15.020 |
| EBITDA (in USD) | 23.029M |
| PE Ratio | -- |
| Volume | 4975326 |
| Diluted Eps TTM | -24.68 |
| Total Assets (in USD) | 4345.355M |
|---|---|
| Total Liabilities (in USD) | 2037.61M |
| Revenue TTM (in USD) | 2579.597M |
| Cash (in USD) | 918.182M |
| Market Cap (in USD) | 3,615.765 M |
| Revenue Per Share TTM | 15.767 |
| Gross Profit TTM (in USD) | 1662.853M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Teladoc Inc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
2 Manhattanville Road, Purchase, NY, United States, 10577
203 635 2002
Employees: 4816
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Jason Nathanial Gorevic | CEO & Director | 1972 |
| 2. | Ms. Mala Murthy | Chief Financial Officer | 1964 |
| 3. | Mr. Adam Christian Vandervoort | Chief Legal Officer & Sec. | 1975 |
| 4. | Mr. Andrew Turitz | Sr. VP of Corp. Devel. | 1973 |
| 5. | Mr. Claus Torp Jensen Ph.D. | Chief Innovation Officer | NA |
| 6. | Dr. George Byron Brooks | Co-Founder | NA |
| 7. | Mr. Mike Waters | Chief Operating Officer | NA |
| 8. | Mr. Richard J. Napolitano | Sr. VP, Chief Accounting Officer & Controller | 1967 |
| 9. | Mr. Patrick Thomas Feeley C.F.A., CPA | VP of Investor Relations | NA |
| 10. | Ms. Courtney Kraemer McLeod | Director of Communication | NA |
Peers
Sector: Healthcare
Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
VEEV
Veeva Systems Inc Class A |
-4.220 2.307% | 181.49 | 54.610 | 33.223 | 12.830 | 6.727 | 11.138 | 58.844 |
|
MTHRF
M3 Inc |
0.000 0.000% | 11 | 29.720 | 25.000 | 0.046 | 4.379 | 0.041 | 0.118 |
|
MTHRY
M3 Inc |
-0.064 1.341% | 4.75 | 31.840 | 26.247 | 0.047 | 4.597 | 0.041 | 0.118 |
|
BTSG
BrightSpring Health Services, Inc. Common Stock |
+1.540 2.595% | 59.83 | 100.220 | 40.650 | 0.690 | 4.925 | 0.918 | 25.797 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -13663.343M | -384.656M | -575.993M | -109.455M | -96.966M |
| Minority Interest | - | - | - | - | - |
| Net Income | -13659.531M | -428.793M | -485.136M | -98.864M | -97.084M |
| Selling General Administrative | 449.855M | 438.007M | 506.684M | 164.456M | 118.782M |
| Gross Profit | 1662.853M | 1382.449M | 703.133M | 368.842M | 289.172M |
| Reconciled Depreciation | 270.643M | 219.621M | 78.087M | 44.952M | 35.602M |
| Ebit | -13739.768M | -238.988M | -418.185M | -73.822M | -65.963M |
| Ebitda | -13469.125M | -14.279M | -340.098M | -28.87M | -30.361M |
| Depreciation And Amortization | 270.643M | 224.709M | 78.087M | 44.952M | 35.602M |
| Operating Income | -13198.482M | -238.988M | -418.185M | -73.822M | -70.854M |
| Other Operating Expenses | 2634.206M | 2271.695M | 1512.147M | 627.129M | 483.87M |
| Interest Expense | 9.27M | 80.365M | 60.495M | 29.013M | 26.112M |
| Tax Provision | -3.812M | 44.137M | -90.857M | -10.591M | 0.118M |
| Interest Income | - | - | - | 29.013M | 26.112M |
| Net Interest Income | -9.27M | -80.365M | -60.495M | -29.013M | -26.112M |
| Income Tax Expense | -3.812M | 44.137M | -90.857M | -10.591M | 0.118M |
| Total Revenue | 2406.84M | 2032.707M | 1093.962M | 553.307M | 417.907M |
| Total Operating Expenses | 1890.219M | 1621.437M | 1121.318M | 442.664M | 355.135M |
| Cost Of Revenue | 743.987M | 650.258M | 390.829M | 184.465M | 128.735M |
| Total Other Income Expense Net | -26861.825M | -145.668M | -157.808M | -35.633M | -4.891M |
| Net Income From Continuing Ops | -13659.531M | -428.793M | -485.136M | -98.864M | -97.084M |
| Net Income Applicable To Common Shares | -13659.531M | -428.793M | -485.136M | -98.864M | -97.084M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Total Assets | 4345.355M | 17734.608M | 17755.281M | 1602.827M | 1528.876M |
| Intangible Assets | 1836.765M | 1910.278M | 2020.864M | 225.453M | 247.394M |
| Other Current Assets | 130.31M | 87.387M | 47.259M | 13.99M | 10.631M |
| Total Liab | 2037.61M | 1688.851M | 1871.477M | 588.802M | 515.757M |
| Total Stockholder Equity | 2307.745M | 16045.757M | 15883.804M | 1014.025M | 1013.119M |
| Other Current Liab | 248.03M | 195.5M | 191.703M | 63.552M | 44.41M |
| Common Stock | 0.163M | 0.16M | 0.15M | 0.073M | 0.07M |
| Capital Stock | 0.163M | 0.16M | 0.15M | 0.073M | 0.07M |
| Retained Earnings | -15008.287M | -1421.454M | -992.661M | -507.525M | -408.661M |
| Good Will | 1073.19M | 14504.174M | 14581.255M | 746.079M | 737.197M |
| Other Assets | 48.54M | 20.703M | 0.002M | 6.545M | 1.401M |
| Cash | 918.182M | 893.48M | 733.324M | 514.353M | 423.989M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 399.769M | 331.013M | 332.649M | 90.181M | 62.439M |
| Current Deferred Revenue | 90.457M | 75.569M | 52.356M | 12.466M | 7.65M |
| Net Debt | 655.148M | 373.964M | 731.97M | -48.949M | -9.306M |
| Short Term Debt | 13.592M | 12.687M | 42.56M | 5.088M | 2.61M |
| Short Long Term Debt | - | - | 42.56M | - | - |
| Short Long Term Debt Total | 1573.33M | 1267.444M | 1465.294M | 465.404M | 414.683M |
| Other Stockholder Equity | 17358.645M | 17473.336M | 16857.797M | 1538.716M | 1434.78M |
| Property Plant Equipment | 29.641M | 74.014M | 28.551M | 10.296M | 10.148M |
| Total Current Assets | 1315.388M | 1225.439M | 1059.607M | 588.002M | 532.736M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 0M | 2.537M | 53.245M | 2.711M | 54.545M |
| Net Receivables | 210.554M | 168.956M | 169.281M | 56.948M | 43.571M |
| Long Term Debt | 1535.288M | 1225.671M | 1379.592M | 440.41M | 414.683M |
| Inventory | 56.342M | 73.079M | 56.498M | - | - |
| Accounts Payable | 47.69M | 47.257M | 46.03M | 9.075M | 7.769M |
| Accumulated Other Comprehensive Income | -42.776M | -6.285M | 18.518M | -17.239M | -13.07M |
| Non Currrent Assets Other | 48.54M | 20.703M | 18.357M | 6.545M | 1.401M |
| Non Current Assets Total | 3029.967M | 16509.169M | 16695.674M | 1014.825M | 996.14M |
| Capital Lease Obligations | 38.042M | 41.773M | 43.142M | 30.082M | - |
| Long Term Debt Total | 1535.288M | 1225.671M | 1379.592M | 440.41M | 414.683M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | 2.507M | 60.901M | 2.496M | 47.1M | 27.823M |
| Total Cashflows From Investing Activities | -167.743M | -72.981M | -590.975M | 25.013M | -257.496M |
| Total Cash From Financing Activities | 6.497M | 40.947M | 859.136M | 35.094M | 645.612M |
| Net Income | -13659.531M | -428.793M | -485.136M | -98.864M | -97.084M |
| Change In Cash | 24.702M | 160.156M | 218.971M | 90.364M | 381.172M |
| Begin Period Cash Flow | 893.48M | 733.324M | 514.353M | 423.989M | 42.817M |
| End Period Cash Flow | 918.182M | 893.48M | 733.324M | 514.353M | 423.989M |
| Total Cash From Operating Activities | 189.292M | 193.99M | -53.511M | 29.869M | -4.86M |
| Depreciation | 270.643M | 219.621M | 78.087M | 44.952M | 35.602M |
| Other Cashflows From Investing Activities | -153.77M | 8.715M | -589.447M | -18.577M | -281.308M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 14.8M | -19.494M | -24.732M | 10.277M | 1.712M |
| Sale Purchase Of Stock | 12.385M | 42.591M | 59.036M | 36.663M | 364.729M |
| Other Cashflows From Financing Activities | 0.613M | 41.086M | 1097.289M | 35.094M | 314.769M |
| Capital Expenditures | 172.764M | 63.934M | 26.042M | 10.9M | 8.407M |
| Change In Working Capital | -60.971M | -50.324M | -90.483M | -0.156M | -1.13M |
| Other Non Cash Items | 13429.139M | 109.1M | 58.648M | 28.103M | 16.23M |
| Free Cash Flow | 16.528M | 130.056M | -79.553M | 18.969M | -13.267M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ARK Innovation ETF | 2 years ago | 12469309 |
| 2. | ARK Disruptive Innovation Full Composite | 2 years ago | 11798135 |
| 3. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 4903946 |
| 4. | ARK Genomic Revolution ETF | 2 years ago | 4101900 |
| 5. | Vanguard Small Cap Index | 2 years ago | 4059282 |
| 6. | ARK Genomic Revolution | 2 years ago | 3971441 |
| 7. | Nikko AM ARK Disruptive Innovation A USD | 2 years ago | 3504128 |
| 8. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 2387927 |
| 9. | Vanguard Small Cap Growth Index Inv | 2 years ago | 2275225 |
| 10. | First Trust Dow Jones Internet ETF | 2 years ago | 2231969 |
| 11. | ARK Next Generation Internet | 2 years ago | 1873293 |
| 12. | ARK Next Generation Internet ETF | 2 years ago | 1833003 |
| 13. | Nikko AM ARK Pstv Chg Innovt P JPY Acc | 2 years ago | 1527963 |
| 14. | DFA US Targeted Value I | 2 years ago | 1326993 |
| 15. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 975432 |
| 16. | ARK Fintech Innovation ETF | 2 years ago | 927269 |
| 17. | CS (Lux) Digital Health Equity SB USD | 2 years ago | 840000 |
| 18. | Vanguard Strategic Equity Inv | 2 years ago | 835197 |
| 19. | Schwab US Small-Cap ETF™ | 2 years ago | 748648 |
| 20. | Fidelity® Extended Market Index | 2 years ago | 646080 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ARK Investment Management LLC | 2 years ago | 20311873 |
| 2. | Vanguard Group Inc | 2 years ago | 15659647 |
| 3. | BlackRock Inc | 2 years ago | 11496326 |
| 4. | Nikko Asset Management Americas Inc | 2 years ago | 7687646 |
| 5. | Sumitomo Mitsui Trust Holdings Inc | 2 years ago | 7687646 |
| 6. | State Street Corporation | 2 years ago | 5130586 |
| 7. | Renaissance Technologies Corp | 2 years ago | 4508984 |
| 8. | State Treasurer State Of Michigan | 2 years ago | 3163000 |
| 9. | Dimensional Fund Advisors, Inc. | 2 years ago | 3066423 |
| 10. | First Trust Advisors L.P. | 2 years ago | 2561817 |
| 11. | Geode Capital Management, LLC | 2 years ago | 2396545 |
| 12. | Morgan Stanley - Brokerage Accounts | 2 years ago | 2078587 |
| 13. | Baillie Gifford & Co Limited. | 2 years ago | 1759908 |
| 14. | Qube Research & Technologies | 2 years ago | 1642682 |
| 15. | Charles Schwab Investment Management Inc | 2 years ago | 1549585 |
| 16. | Millennium Management LLC | 2 years ago | 1520756 |
| 17. | Federated Hermes Inc | 2 years ago | 1499322 |
| 18. | Balyasny Asset Management LLC | 2 years ago | 1466486 |
| 19. | Credit Suisse First Boston (CSFB) | 2 years ago | 1407630 |
| 20. | Man Group PLC | 2 years ago | 1242043 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...